Douglas Elliman Inc
NYSE:DOUG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Douglas Elliman Inc
NYSE:DOUG
|
US |
|
Feitian Technologies Co Ltd
SZSE:300386
|
CN |
|
B
|
Bedmutha Industries Ltd
NSE:BEDMUTHA
|
IN |
|
G
|
GIIR Inc
KRX:035000
|
KR |
|
A
|
AstraZeneca PLC
BMV:AZNN
|
UK |
|
E
|
Eurocash SA
WSE:EUR
|
PL |
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
G
|
Geumhwa PSC Co Ltd
KOSDAQ:036190
|
KR |
Income Statement
Earnings Waterfall
Douglas Elliman Inc
Income Statement
Douglas Elliman Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
6
|
6
|
|
| Revenue |
774
N/A
|
881
+14%
|
1 140
+29%
|
1 287
+13%
|
1 353
+5%
|
1 389
+3%
|
1 362
-2%
|
1 280
-6%
|
1 153
-10%
|
1 058
-8%
|
970
-8%
|
949
-2%
|
956
+1%
|
942
-1%
|
952
+1%
|
966
+2%
|
996
+3%
|
1 049
+5%
|
1 034
-1%
|
1 031
0%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(761)
|
(842)
|
(1 056)
|
(1 189)
|
(1 251)
|
(1 294)
|
(1 294)
|
(1 244)
|
(1 158)
|
(1 093)
|
(1 027)
|
(1 010)
|
(1 018)
|
(1 005)
|
(1 010)
|
(1 024)
|
(1 046)
|
(1 078)
|
(1 066)
|
(1 057)
|
|
| Selling, General & Administrative |
(752)
|
(834)
|
(1 048)
|
(1 180)
|
(1 243)
|
(1 285)
|
(1 286)
|
(1 235)
|
(1 150)
|
(1 085)
|
(1 019)
|
(1 002)
|
(1 010)
|
(997)
|
(1 002)
|
(1 016)
|
(1 038)
|
(1 070)
|
(1 058)
|
(1 048)
|
|
| Depreciation & Amortization |
(9)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
|
| Operating Income |
14
N/A
|
39
+188%
|
84
+116%
|
98
+16%
|
102
+5%
|
96
-6%
|
67
-30%
|
37
-46%
|
(5)
N/A
|
(35)
-680%
|
(58)
-64%
|
(61)
-6%
|
(62)
-2%
|
(63)
-2%
|
(59)
+7%
|
(57)
+2%
|
(50)
+13%
|
(29)
+41%
|
(31)
-7%
|
(26)
+18%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
1
|
1
|
1
|
1
|
0
|
2
|
2
|
3
|
5
|
4
|
5
|
6
|
6
|
7
|
7
|
(15)
|
(7)
|
(9)
|
(28)
|
(22)
|
|
| Non-Reccuring Items |
(63)
|
(5)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(19)
|
(19)
|
(19)
|
(19)
|
(3)
|
(3)
|
(12)
|
|
| Total Other Income |
2
|
0
|
(3)
|
(3)
|
(2)
|
(2)
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(46)
N/A
|
35
N/A
|
81
+131%
|
94
+17%
|
101
+7%
|
96
-5%
|
71
-25%
|
41
-42%
|
0
-100%
|
(32)
N/A
|
(55)
-69%
|
(57)
-5%
|
(58)
-2%
|
(76)
-30%
|
(71)
+6%
|
(91)
-29%
|
(76)
+17%
|
(42)
+45%
|
(63)
-50%
|
(60)
+4%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
(0)
|
(1)
|
(2)
|
(2)
|
(5)
|
(10)
|
(9)
|
(7)
|
2
|
9
|
10
|
15
|
9
|
7
|
5
|
(1)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(46)
|
35
|
80
|
93
|
99
|
91
|
62
|
32
|
(6)
|
(31)
|
(46)
|
(47)
|
(43)
|
(67)
|
(64)
|
(86)
|
(77)
|
(42)
|
(62)
|
(60)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Net Income (Common) |
(46)
N/A
|
35
N/A
|
80
+130%
|
93
+17%
|
99
+7%
|
91
-8%
|
62
-32%
|
32
-47%
|
(6)
N/A
|
(31)
-384%
|
(46)
-50%
|
(47)
-2%
|
(43)
+8%
|
(66)
-55%
|
(63)
+5%
|
(85)
-35%
|
(76)
+10%
|
(41)
+47%
|
(62)
-51%
|
(59)
+4%
|
|
| EPS (Diluted) |
-0.57
N/A
|
0.42
N/A
|
0.97
+131%
|
1.13
+16%
|
1.21
+7%
|
1.12
-7%
|
0.76
-32%
|
0.4
-47%
|
-0.08
N/A
|
-0.38
-375%
|
-0.56
-47%
|
-0.57
-2%
|
-0.52
+9%
|
-0.8
-54%
|
-0.76
+5%
|
-1.02
-34%
|
-0.91
+11%
|
-0.49
+46%
|
-0.74
-51%
|
-0.7
+5%
|
|